# CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

> **NCT03652181** · — · COMPLETED · sponsor: **University of Chicago** · enrollment: 123 (actual)

## Conditions studied

- CCM
- Cavernoma
- Cerebral Cavernous Malformation
- Cerebral Cavernous Malformations 1
- Cerebral Cavernous Malformations 2
- Cerebral Cavernous Malformations 3
- Cavernous Angioma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03652181
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-20
- **Primary completion:** 2022-11-03
- **Final completion:** 2022-11-03
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2024-06-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03652181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03652181, "CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03652181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*